Last Updated: September 23, 2026

IBUPROFEN AND DIPHENHYDRAMINE CITRATE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Ibuprofen And Diphenhydramine Citrate, and what generic alternatives are available?

Ibuprofen And Diphenhydramine Citrate is a drug marketed by Aurobindo Pharma, Dr Reddys Labs Ltd, Perrigo R And D, and Pld Acquisitions Llc. and is included in four NDAs.

The generic ingredient in IBUPROFEN AND DIPHENHYDRAMINE CITRATE is diphenhydramine citrate; ibuprofen. There is one drug master file entry for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the diphenhydramine citrate; ibuprofen profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for IBUPROFEN AND DIPHENHYDRAMINE CITRATE?
What are the global sales for IBUPROFEN AND DIPHENHYDRAMINE CITRATE?
What is Average Wholesale Price for IBUPROFEN AND DIPHENHYDRAMINE CITRATE?

Summary for IBUPROFEN AND DIPHENHYDRAMINE CITRATE

US Patents:	0
Applicants:	4
NDAs:	4
Finished Product Suppliers / Packagers:	30
Clinical Trials:	2
Patent Applications:	7
DailyMed Link:	IBUPROFEN AND DIPHENHYDRAMINE CITRATE at DailyMed

Drug patent expirations by year for IBUPROFEN AND DIPHENHYDRAMINE CITRATE

Recent Clinical Trials for IBUPROFEN AND DIPHENHYDRAMINE CITRATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Dr. Reddy's Laboratories Limited	Phase 1

See all IBUPROFEN AND DIPHENHYDRAMINE CITRATE clinical trials

Pharmacology for IBUPROFEN AND DIPHENHYDRAMINE CITRATE

Drug Class	Histamine-1 Receptor Antagonist Nonsteroidal Anti-inflammatory Drug
Mechanism of Action	Cyclooxygenase Inhibitors Histamine H1 Receptor Antagonists

US Patents and Regulatory Information for IBUPROFEN AND DIPHENHYDRAMINE CITRATE

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Aurobindo Pharma	IBUPROFEN AND DIPHENHYDRAMINE CITRATE	diphenhydramine citrate; ibuprofen	TABLET;ORAL	216204-001	May 31, 2022		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Pld Acquisitions Llc	IBUPROFEN AND DIPHENHYDRAMINE CITRATE	diphenhydramine citrate; ibuprofen	TABLET;ORAL	211404-001	Apr 11, 2024		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Dr Reddys Labs Ltd	IBUPROFEN AND DIPHENHYDRAMINE CITRATE	diphenhydramine citrate; ibuprofen	TABLET;ORAL	090619-001	Jul 8, 2009		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Perrigo R And D	IBUPROFEN AND DIPHENHYDRAMINE CITRATE	diphenhydramine citrate; ibuprofen	TABLET;ORAL	079113-001	Dec 22, 2008		OTC	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.